Issue 1, 2021

Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds

Abstract

Covering: up to the beginning of 2020

Many natural substances have been transformed again and again with regard to their pharmaceutical-medical potential, including new members of a growing class of natural products, the flavaglines. Important representatives are rocaglamide and silvestrol, isolated from the Aglaia species, which are highlighted here. These products started as potential anti-tumor agents five decades ago and have recently proved to be very promising antiviral agents, especially against RNA viruses. Today they are discussed as potential starting compounds for developing drug candidates and therapeutics.

Graphical abstract: Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds

Article information

Article type
Highlight
Submitted
14 Maijs 2020
First published
23 Jūl. 2020

Nat. Prod. Rep., 2021,38, 18-23

Rocaglamide and silvestrol: a long story from anti-tumor to anti-coronavirus compounds

G. Schulz, C. Victoria, A. Kirschning and E. Steinmann, Nat. Prod. Rep., 2021, 38, 18 DOI: 10.1039/D0NP00024H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements